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Abstract
P2Y2 receptors, which are equally responsive to ATP and UTP, can trigger intracellular signaling events, such as
intracellular calcium mobilization and mitogen-activated protein (MAP) kinase phosphorylation in polymorphonuclear
leukocytes (PMN). Moreover, extracellular nucleotides have been shown to prime chemoattractant-induced superoxide
production. The aim of our study was to investigate the mechanism responsible for the priming effect of extracellular
nucleotides on reactive oxygen species (ROS) production induced in human neutrophils by two different chemo-
attractants: formyl-methionyl-leucyl-phenylalanine (fMLP) and interleukin-8 (IL-8). Nucleotide-induced priming of ROS
production was concentration- and time-dependent. When UTP was added to neutrophil suspensions prior to
chemoattractant, the increase of the response reached the maximum at 1 min of pre-incubation with the nucleotide.
UTP potentiated the phosphorylation of p44/42 and p38 MAP kinases induced by chemoattractants, however the P2
receptor-mediated potentiation of ROS production was still detectable in the presence of a SB203580 or U0126,
supporting the view that MAP kinases do not play a major role in regulating the nucleotide-induced effect. In the presence
of thapsigargin, an inhibitor of the ubiquitous sarco-endoplasmic reticulum Ca
2+-ATPases in mammalian cells, the effect
of fMLP was not affected, but UTP-induced priming was abolished, suggesting that the release of calcium from
thapsigargin-sensitive intracellular stores is essential for nucleotide-induced priming in human neutrophils.
Introduction
Although ATP is abundantly present in living cells, it is
mainly conﬁned to the intracellular environment where it
commonly reaches concentrations in low millimolar range
[1]. ATP is found at even higher concentrations (approx-
imately 150 mM) in chromafﬁn cells of the adrenal
medulla [2]. There is strong evidence indicating that
endothelial cells, activated platelets, sympathetic nerve
endings as well as damaged cells can release signiﬁcant
amounts of ATP in the extracellular medium under a
variety of pathological conditions such as atherosclerosis,
hypertension, ischemia, and inﬂammation [1, 3]. UTP,
although not as abundant as ATP, has been reported to be
released from platelets, leukocytes, primary airway epithe-
lial cells, rat astrocytes and several cell lines [4, 5]. Most
mammalian cell types, including leukocytes, express on the
plasma membrane receptors for extracellular nucleotides as
well as ectonucleotidases, enzymes which are able to
quickly hydrolyze nucleotides [6]. It has been previously
shown that ATP causes an enhancement of N-formyl-
methionyl-leucyl-phenylalanine (fMLP)-stimulated super-
oxide anion (O2
j) generation [7, 8] when added to human
polymorphonuclear neutrophils at concentrations similar to
those attained extracellularly at sites of platelet thrombus
formation (0.1 to 20 mM). However, ATP by itself was
unable to cause superoxide anion generation in isolated
neutrophils [8]. Priming of the neutrophil respiratory burst
has been implicated in the pathogenesis of multi-system
organ failure after sepsis and trauma and appears to be
mediated by multiple signaling pathways, depending on the
particular priming agent and on the agonist [9]. MAP
kinases have been shown to participate in the priming
effect of TNF-a and granulocyte-macrophage colony-
stimulating factor (GM-CSF) but not in the case of
platelet-activating factor (PAF) [9].
We have previously shown that the main nucleotide
receptor mediating nucleotide-induced responses in neu-
trophils is the P2Y2 receptor, which is equally responsive
to ATP and UTP [10]. In the present study we performed a
pharmacological characterization of the priming effect of
nucleotides on ROS production induced by fMLP or IL-8.
We also explored the effect of extracellular nucleotides on
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potentiation effect of nucleotides. We found that although
the phosphorylation of p44/42 (Erk) and p38 MAP kinases
is enhanced by extracellular nucleotides, this event does
not participate in priming. In addition, we investigated the
role played by free cytosolic calcium in the priming effect of
nucleotides. In isolated neutrophils, nucleotides cause
increase of cytosolic free calcium by release from intracel-
lular stores and through inﬂux [11]. In calcium-depleted
neutrophils fMLP-induced ROS production was signiﬁ-
cantly inhibited but the potentiating effect of nucleotides
was still present, although not as robust as in cells main-
tained in medium containing physiological concentrations
of calcium.
We showed for the ﬁrst time that thapsigargin, a widely
usedinhibitoroftheubiquitoussarco-endoplasmicreticulum
Ca
2+-ATPases in mammalian cells, is able to selectively
block the potentiating effect of nucleotides on fMLP-
induced ROS production. Our data support the view that
the release of calcium from thapsigargin-sensitive intracel-
lular stores is essential for nucleotide-induced priming.
Materials and methods
Reagents. All nucleotides, SB203580 (4-(4-Fluorophenyl)-
2-(4-methylsulﬁnylphenyl)-5-(4-pyridyl)-1H-imidazole),
U0126 (1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenyl-
mercapto) butadiene), brefeldin A, thapsigargin, and
bovine serum albumin (BSA; fraction V) were obtained
from Sigma (St. Louis, Missouri, USA). Dextran T500,
Ficoll-Paque were from Amersham Biosciences (Piscat-
away, New Jersey, USA). CDP-Star with Nitro-Block II
\
from Tropix (Bedford, Massachusetts, USA) was used for
chemiluminescent detection in Western blotting experi-
ments. Fura-2 AM was from Molecular Probes (Eugene,
Oregon, USA) and IL-8 was from Peprotech (Rocky Hill,
New Jersey, USA). Polyclonal anti phospho-p44/42 MAP
kinase (Thr202/Tyr204), anti-p44/442 MAP kinase, anti
phospho-p38 MAP kinase (Thr180/Tyr182) antibodies, and
anti p38 MAP kinase were from Cell Signaling Technology
(Beverly, Massachusetts, USA).
Neutrophil isolation was performed as previously described
[12]. Brieﬂy, venous blood was collected upon written
consent from healthy subjects in polypropylene tubes
containing ACD anticoagulant (1.5% citric acid, 2.5%
sodium citrate, 2% dextrose). Blood was mixed with an
equal volume of 3% dextran T500 in saline. Erythrocytes
were allowed to sediment for 20 min then leukocyte rich
plasma was subjected to centrifugation on Ficoll-Paque at
400g for 45 min. The pellet was collected and the
contaminating erythrocytes were removed by hypotonic
lysis. Isolated neutrophils were resuspended in Hank’s
balanced salt solution (HBSS) containing 0.2% BSA.
Neutrophils were counted using a Reichert-Jung hema-
cytometer (Hausser Scientiﬁc, Horsham, Pennsylvania,
USA). Cell viability was checked by the Trypan blue
exclusionmethod andwas routinely foundgreaterthan96%.
Measurement of cytoplasmic free Ca
2+ concentration.
Isolated neutrophils were incubated for 45 min at room
temperature in HBSS containing bovine serum albumin
Figure 1. UTP potentiates fMLP- or IL-8-induced ROS production in a time-dependent manner. Human neutrophils were isolated and ROS production
was measured as described under Materials and methods. (A) and (B) The effect of fMLP (10 nM) or IL-8 (10 nM) was measured when administered
alone (empty bars) or simultaneously with 10 mM UTP (closed bars). (C) and (D) The effect of fMLP or IL-8 was measured when added at different
intervals after the addition of UTP. Averages T SEM of peak luminescence signal measured in 4Y6 experiments are shown. The luminescence peak
measured upon the addition of a ﬁnal concentration of 200 mMo fH 2O2 to medium containing isoluminol (5 mM) and horseradish peroxidase (1 U/ml)
corresponds to 100 U on the Y-axes. (*P G 0.05).
360 F. Tuluc et al.0.2% and 1 mM Fura-2 AM. The cells were washed twice
and then resuspended at a concentration of 3  10
6/ml in
HBSS containing BSA 0.2% and cytoplasmic free Ca
2+
concentration was measured as previously described [12].
Brieﬂy, aliquots of 0.5 ml were placed in disposable
methacrylate cuvettes under stirring conditions at 37 -C.
Intracellular calcium concentrations were recorded during
agonist stimulation using excitation wavelengths of 340
and 380 nm and the emission was monitored at 510 nm
using an AB2 luminescence spectrophotometer (Spec-
tronics Instruments, Rochester, New York, USA). Cyto-
plasmic concentrations of calcium were calculated
according to Tsien’s ratiometric method [13]. Averages of
peak intracellular calcium concentrations were compared.
Measurement of ROS production. The release of ROS
was measured as described elsewhere [14]. Brieﬂy,
horseradish peroxidase (1 U/ml) and isoluminol (5 mM)
were added to neutrophil suspensions (2  10
6/ml) in a
glass cuvette under stirring conditions, at 37 -C in a lumi-
aggregometer model 560-CA (Chronolog Corp., Haver-
town, Pennsylvania, USA). The cells were allowed to
equilibrate for several minutes and reagents were added to
the cell suspension while recording the luminescence
signal on a chart recorder. For standardization purposes,
hydrogen peroxide was used to assess the sensitivity of the
peroxidase-isoluminol system and for normalization of data.
The luminescence peak measured upon the addition of a
ﬁnal concentration of 200 mMo fH 2O2 to medium
containing isoluminol (5 mM) and horseradish peroxidase
(1 U/ml) was considered equal to 100 U. Averages of peak
luminescence signals were compared.
Western blotting. Isolated humanneutrophils(610
6/ml)
were incubated with UTP (10 mM) or solvent for 1 min at
37 -C then cells were stimulated with 10 nM fMLP or
IL-8 for 2 min. The stimulation was terminated by adding
to each sample an equal volume of 2 lysis buffer con-
taining a mixture of protease and phosphatase inhibitors.
The ﬁnal concentrations of reagents in the lysis medium
were: 25 mM TrisYHCl, 150 mM NaCl, 5 mM EDTA, 1%
Triton X-100, 1 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml
aprotinin, 1 mM sodium vanadate, 2 mM sodium pyro-
phosphate, 10 mM b-glycerol phosphate. The lysis was
performed on ice for 20 min followed by centrifugation of
the samples at 13,000 rpm for 5 min. A volume of 200
ml of the cytosolic fraction (the supernatant) was collected
and mixed with 100 ml of sample buffer containing: 6%
sodium dodecyl sulphate, 30% glycerol, 3 mM EDTA,
0.03% phenol red. Proteins were separated by SDS-
polyacrylamide gel electrophoresis, transferred to Immun-
Blot
\ PVDF membrane (Bio-Rad, Hercules, California,
USA) and incubated for 30 min in Tris buffered saline
(TTBS; 20 mM Tris, 150 mM NaCl, 0.05% Tween 20; pH
7.5) containing 2% BSA (blocking buffer). Membranes
were incubated overnight at 4 -C in the presence of the
indicated primary antibody, which was diluted 1:1,000 in
blocking buffer. Membranes were washed and incubated
with appropriate secondary antibodies conjugated with
alkaline phosphatase for 30 min. Membranes were exten-
sively washed and CDP-Star with Nitro-Block II
\ (Tropix,
Bedford, Massachusetts, USA) was used for chemilumi-
nescent detection of the reactive proteins on a Fujiﬁlm
LAS-1000 CCD system.
Data analysis. Statistical comparisons were made using
one way analysis of variance (ANOVA). A P value G 0.05
was considered signiﬁcant.
Results
Nucleotides potentiate ROS production induced by fMLP
or IL-8 in a time- and dose- dependent manner
We performed a pharmacological characterization of the
potentiating effect of extracellular nucleotides on the
production of reactive oxygen species caused by two
well-known chemoattractants, fMLP and IL-8. We tested
ATP and UTP, two nucleotides that have been shown to be
released in the extracellular medium under physiological or
pathological conditions. When added alone to neutrophil
suspensions, ATP and UTP did not cause measurable ROS
production. However, both nucleotides were able to
enhance the production of ROS induced by either IL-
Figure 2. UTP and ATP potentiate fMLP- or IL-8-induced ROS
production in a dose-dependent manner. Human neutrophils were isolated
and ROS production was measured as described under Materials and
methods. The effect of 10 nM fMLP (A) or 10 nM IL-8 (B) was measured
when administered alone or 1 min after the addition of increasing
concentrations of UTP (circles) or ATP (squares). Averages T SEM of
peak luminescence signal measured in 3Y5 experiments are shown. The
luminescence peak measured upon the addition of a ﬁnal concentration of
200 mMo fH 2O2 to medium containing isoluminol (5 mM) and horseradish
peroxidase (1 U/ml) corresponds to 100 U on the Y-axes. (*P G 0.05 when
compared to the values measured in the absence of nucleotides.)
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chemoattractant was added to neutrophil suspensions, a
signiﬁcant potentiation of the effect of chemoattractant was
measured (Figures 1A and B). The potentiation of ROS
production induced by IL-8 was higher (2.6-fold increase)
as compared to the effect of fMLP (1.7-fold). In order to
determine if the potentiation effect of nucleotides is time-
dependent, UTP (10 mM) was added to neutrophil
suspension at different intervals prior the addition of fMLP
(10 nM) or IL-8 (10 nM). The maximal potentiating effect
of UTP was detected when the addition of nucleotide was
performed at 1 min before the addition of the chemo-
attractant (Figures 1C and D).
The relationship between the concentration of nucleotide
and the priming effect was assessed by administering
different concentrations of nucleotide at a ﬁxed interval (1
min) before the addition of chemoattractant (Figure 2). The
maximal effect of nucleotides was obtained at 10 mM,
which is consistent with the potency described for these
agonists at P2Y2 receptors expressed in 1321N1 cells,
which are devoid of endogenous P2 receptors [15].
Nucleotides potentiate the phosphorylation of MAP kinases
induced by fMLP and IL-8
MAP kinases have been rep o r t e dt op l a yar o l ei n
mediating neutrophil functions. In the present study we
Figure 3. UTP induces MAP kinase phosphorylation. (A) and (B) Isolated human neutrophils (6 million/ml) were incubated with UTP (10 mM) or
solvent for 1 min at 37 -C then cells were stimulated for 2 min with fMLP or IL-8, as indicated. Cells were lysed and solubilized proteins were separated
by SDS-polyacrylamide gel electrophoresis. The detection of phosphorylated MAP kinases was performed as described under Materials and methods.
(C) Densitometric analysis of images obtained from three Western blotting experiments. Data were normalized for the maximum effect obtained in cells
stimulated with UTP and fMLP, which was considered equal to 100 arbitrary units (AU).
Figure 4. Inhibition of p38 or p44/42 MAP kinase has minor effect on
the potentiating effect of nucleotides on ROS production. Isolated
neutrophils were incubated with SB203580 (10 mM) or U0126 (3 mM)
for 15 min then ROS production was measured as described under
Materials and methods. The effect of fMLP (10 nM) or IL-8 (10 nM) was
determined when administered 1 min after the addition of UTP (10 mM;
closed bars) or solvent (open bars). Averages T SEM of peak lumines-
cence signal measured in 4 Y5 experiments are shown (*P G 0.05).
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nucleotide-induced potentiation of ROS production. Both
p44/42 and p38 MAP kinases have been shown to be
activated by upstream kinases, which are able to phosphor-
ylate speciﬁc residues. The p44/42 MAP kinase is activated
by dual phosphorylation at Thr202 and Tyr204 [16], while
p38 MAP kinase activation requires dual phosphorylation
at Thr180 and Tyr182 [17]. We determined the phosphor-
ylation of p44/42 and p38 MAP kinases by Western
blotting, using phospho-speciﬁc antibodies.
UTP was able to weakly phosphorylate p44/42 MAP
kinase and had a more prominent effect on the phosphor-
ylation of p38 MAPK (Figure 3). We have previously
shown that ATP had a similar effect on the phosphoryla-
tion of MAP kinases [10] consistent with the view that
ATP and UTP act on a common receptor on human
neutrophils. When added to neutrophils 60 s prior to the
Table 1. The effect of MAP kinase inhibitors on fMLP- or IL-8-induced
ROS production in human neutrophils.
Control SB203580 (10 mM) U0126 (3 mM)
Solvent + fMLP 25.3 T 2.3 8.5 T 2.5 9.5 T 1.5
UTP + fMLP 95.0 T 14.0 54.6 T 19.7 80.0 T 18.4
Fold increase 3.8 6.4 8.4
Solvent + IL-8 18.0 T 5.6 6.4 T 2.8 5.9 T 4.3
UTP + IL-8 79.0 T 7.0 42.7 T 9.3 42.4 T 17.4
Fold increase 4.4 6.7 7.2
ROS production was measured in isolated human neutrophils as described
under Materials and methods. Cells were incubated with UTP (10 mM) or
solvent then fMLP (10 nM) or IL-8 (10 nM) were added to the medium.
Averages T SEM of peak luminescence signal are presented. The
luminescence peak measured upon the addition of a ﬁnal concentration
of 200 mMo fH 2O2 to medium containing isoluminol (5 mM) and horse-
radish peroxidase (1 U/ml) corresponds to 100 U.
Figure 5. Nucleotides potentiate the increase of free cytosolic calcium triggered by fMLP or IL-8 in a dose-dependent manner. (A) and (B) Human
neutrophils were isolated and intracellular calcium increase was measured as described under Materials and methods. The effect of fMLP (10 nM) or IL-
8 (10 nM) was measured when administered 2 min after the addition of different concentrations of UTP (circles) or ATP (squares). Averages T SEM of
peak intracellular calcium concentrations measured in 4Y5 experiments are shown. (C) Representative tracings obtained in neutrophils stimulated with
chemoattractant alone (10 nM fMLP or 10 nM IL-8) or with nucleotide (10 mM UTP or 10 mM ATP) followed by chemoattractant. The reagents were
added to cell suspensions where indicated on each individual tracing.
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IL-8-induced phosphorylation of p44/42 kinase. Although
UTP potentiated fMLP-induced MAP kinase phosphoryla-
tion and IL-8-induced phosphorylation of p38 MAP kinase,
these effects were much less prominent.
The potentiating effects of UTP on ROS production is not
affected by inhibition of MAP kinases
To determine whether or not MAP kinases play an essen-
tial role in the priming effect of nucleotides on superoxide
production, we used SB203580 and U0126 as selective in-
hibitors of p38 and p44/42 MAP kinases, respectively. It
has been previously shown that the pyridinyl imidazole
SB203580 inhibits p38 kinase activity through competition
with ATP and that its selectivity is probably determined by
differences in nonconserved regions within or near the
ATP binding pocket [18]. SB203580 is able to inhibit p38
MAP kinase activity in cells when used in concentrations
up to 10 mM [19]. U0126 is a potent inhibitor of MEK1/2,
the enzymes responsible for the phosphorylation of p44/42
MAP kinase [20]. We have determined that concentrations
of U0126 as low as 3 mM are able to completely inhibit the
Erk phosphorylation induced by fMLP or by nucleotides in
isolated human neutrophils (data not shown). Consistent
with previous reports [21Y24], we found that SB203580
has a modest but statistically signiﬁcant inhibitory effect
on fMLP-induced ROS production (P G 0.05; Figure 4). A
similar effect was observed in the case of U0126. Although
the levels of ROS measured in the presence of UTP were
signiﬁcantly lower in the presence of SB203580 or U0126,
the potentiating effect of nucleotides was not inhibited by
SB203580 (Table 1). In the case of IL-8, SB203580 or
U0126 partially inhibited ROS production but they had no
inhibitory effect on the potentiating effect of UTP.
Nucleotides potentiate intracellular calcium increase
elicited by fMLP or IL-8. We and others [7, 10, 11, 25]
have previously shown that extracellular nucleotides can
cause intracellular calcium increase in isolated human
neutrophils and this effect is partially resistant to the
treatment with pertussis toxin. The intracellular calcium
levels remain elevated for about 2 min before they return
to baseline levels. A second addition of nucleotide causes
no subsequent response due to receptor desensitization,
which has been extensively described elsewhere [26, 27].
Although cross-desensitization between different receptors
for chemoattractants has been described [28Y30], nucleo-
tides do not desensitize the responses to fMLP or IL-8 [28,
31]. Here we investigated the effect of the naturally
occurring nucleotides ATP and UTP on the subsequent
responses elicited by fMLP or IL-8. Neutrophils were
stimulated with nucleotides and after 2 min, when the
concentration of cytosolic free calcium returned to values
close to the resting levels, fMLP (10 nM) or IL-8 (10
nM) were added to cell suspensions. We found that the
responses to chemoattractants were enhanced by nucleo-
tides in a dose-dependent manner, the maximum response
being reached at 10 mM (Figure 5). There were no
signiﬁcant differences between the effects caused by ATP
and UTP.
Pretreatment of neutrophils for 20 min with 10 mM
brefeldin A, a widely used disrupter of calcium stores from
Golgi apparatus [32] did not affect the potentiating effect
induced by UTP on [Ca
2+]i peak.
Thapsigargin prevents the potentiating effect of nucleotides
on ROS production
It is well established that the increase of cytosolic calcium
in neutrophils relies both on mobilization from intracellular
stores and on inﬂux [11]. Nucleotides and chemoattractants
are able to trigger both mechanisms hence we investigated
the role of calcium originating from different sources on
the potentiating effect of nucleotides on chemoattractant-
induced ROS production.
When neutrophils are kept in calcium free medium for
an extended period of time their responses to chemo-
attractants are markedly diminished due to depletion of
intracellular stores of calcium [33]. However, when neutro-
phils were placed in calcium-free medium and fMLP-
induced ROS production was immediately measured, we
Figure 6. Thapsigargin selectively blocks the potentiating effect of UTP
on fMLP-induced ROS production. Isolated neutrophils were resuspended
in medium containing 2 mM CaCl2 and 1 mM MgCl2 (closed bars) or in
calcium and magnesium-free medium (empty bars). Cells were pre-treated
for 20 min with solvent (A) or 100 nM thapsigargin (B). UTP (10 mm) or
solvent was added to the medium followed after 1 min by fMLP (10 nM).
ROS production was determined as described under Materials and
methods Averages T SEM of peak luminescence signal measured in 4Y5
experiments are shown. The luminescence peak measured upon the
addition of a ﬁnal concentration of 200 mMo fH 2O2 to medium containing
isoluminol (5 mM) and horseradish peroxidase (1 U/ml) corresponds to
100 U on the Y-axes. (*P G 0.05).
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still signiﬁcant. When cells were incubated with thapsi-
gargin (100 nM) for 20 min in medium containing 2 mM
CaCl2, fMLP-induced ROS production was not affected,
however the potentiating effect of UTP was completely
abolished (Figures 6 and 7). Thapsigargin also inhibited the
potentiating effect of UTP on IL-8 induced ROS produc-
tion (data not shown). Thapsigargin caused a transient ROS
production (Figure 7B) that may be due to activation of
store-operated calcium entry. When cells were resuspended
in calcium-free medium the addition of thapsigargin did
not trigger ROS production and abolished fMLP-induced
effect. A transient calcium increase was recorded when
thapsigargin was added to neutrophils placed in calcium-
free medium (Figure 7C). Pretreatment of neutrophils with
brefeldin A (10 mM) failed to induce ROS production and
did not affect the potentiating effect induced by UTP on
ROS production (data not shown).
Discussion
In the present study we performed a pharmacological
characterization of the priming effect of extracellular
nucleotides on isolated human neutrophils. We determined
that ATP and UTP can cause an immediate potentiating
effect on ROS production, but the maximal effect elicited
by nucleotides occurs after 1 min of exposure to nucleo-
tide. This phenomenon may have physiological relevance
since increased concentrations of nucleotides are expected
to be present in the capillaries located closed to the
inﬂammatory site. Nucleotides may function as a sensitiz-
ing factor, rendering the neutrophils the ability to respond
to very low concentrations of chemoattractants. Thus, it is
conceivable that nucleotides may prime the neutrophils in
such a manner that they will be able to react at maximal
levels when reaching the environment with elevated con-
centrations of chemoattractants.
We also determined that the potentiating effect of ATP
and UTP is detectable at concentrations as low as 100 nM
and reaches a maximum at 10 mM, which is consistent with
the concentration of ATP expected to be present in the
extracellular environment of the inﬂammatory site.
Under physiological and pathological conditions the
effect of ATP on human neutrophils is expected to be
dependent on the activity of ectonucleotidases on most
cells, these enzymes being able to quickly degrade the
nucleotide triphosphates to nucleotide diphosphates, nucle-
otide monophosphates and ﬁnally to nucleosides [1,
34Y36]. In some experiments ATP and UTP were used in
Figure 7. The effect of thapsigargin on the potentiating effect of UTP on fMLP-induced ROS production. Isolated neutrophils were incubated for 20
min with solvent (tracings in (A)) or 100 nM thapsigargin (Thp tracing in (B)). UTP (10 mM) and fMLP (10 nM) were added as indicated in each panel.
Vertical bar corresponds to the luminescence peak measured upon the addition of a ﬁnal concentration of 200 mMo fH 2O2 to medium containing
isoluminol (5 mM) and horseradish peroxidase (1 U/ml). Tracings are representative for data shown in Figure 6. (C) Thapsigargin (100 nM) was added to
fura-2 loaded neutrophils resuspended in calcium-free medium. Intracellular calcium concentration was recorded as described under Materials and
methods.
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ments we chose to use UTP, since UTP is less likely to be
degraded by ectonucleotidases. Thus, we avoided the
biphasic effect that ATP has on neutrophils due to its
degradation to adenosine, which has mainly inhibitory
effects on this cell type [34]. Under our experimental
conditions we observed that the potentiating effect of UTP
tended to be higher as compared to the effect of ATP
(Figure 2), probably due to the fact that UTP is less af-
fected by enzymatic degradation.
Although high concentrations of ADP (100 mM) caused
a potentiating effect on fMLP-induced ROS production,
this effect was most likely due to the contaminating ATP
from commercially available nucleotides. Treatment of
ADP with glucose (22 mM) and hexokinase (1 U/ml) for
10 min in order to convert the contaminating ATP to ADP
[37, 38] resulted in no potentiating effect of ADP (data not
shown). AMP has also been reported as inactive at human
neutrophils [39].
UTP is degraded by ectonucleotidases to UDP, UMP and
uridine, and all these metabolites failed to affect the
responses to chemoattractants (data not shown). Hence,
while the stimulatory effect of ATP might be counter-
balanced by adenosine, the effect of UTP may be longer
lasting, since uridine is inactive. However, these hypoth-
eses are not proven since the real concentrations of
nucleotide, as well as the activity of ectonucleotidases at
the inﬂammatory sites are difﬁcult to quantify.
MAP kinases have been previously shown to be involved
in ROS production; however, their involvement in nucle-
otide-mediated priming effect has not been tested. To
determine if the activation of MAP kinases plays a role in
the priming effect of nucleotides, we used SB203580, a
p38 MAP kinase inhibitor, and U0126, an inhibitor of
MEK1/2, the kinases responsible for the phosphorylation
of p44/42. Since the P2 receptor-mediated potentiation of
ROS production persisted in the presence of SB203580 or
U0126, it appears that MAP kinases do not play a major
role in the nucleotide-induced effect. Moreover, compari-
son of the ratio between the response elicited by chemo-
attractant alone and the response in the presence of UTP
(Table 1) revealed no inhibitory effect of SB203580 or
U0126 on UTP-induced potentiation. On the contrary, an
increase of the potentiating effect of UTP was observed for
both IL-8 and fMLP in the presence of MAP kinase
inhibitors. A possible negative role of MAP kinases on the
UTP-mediated potentiation of ROS production may ex-
plain the enhanced UTP-induced effect in the presence of
MAP kinase inhibitors.
Stimulation of PMNs with IL-8 or fMLP results in
increases in cytosolic calcium due to a combination of
intracellular calcium release and inﬂux of extracellular
calcium. The ﬁrst rapid increase in cytosolic calcium is due
to PLC activation followed by IP3 generation and calcium
release, mainly from endoplasmic reticulum. Subsequently,
emptying of the intracellular calcium stores triggers a
longer lasting inﬂux of extracellular calcium through
membrane channels (for a review see Niggli, 2003 [40]).
PLC pathway has been demonstrated to have an important
role in chemoattractant-mediated production of superoxide
and regulation of certain protein kinases, but it has no
major role in chemotaxis [41]. Recently, novel functionally
active intracellular calcium stores have been identiﬁed in
various cell types, the most important being Golgi
apparatus and lysosomes [42] but the roles of these calcium
sources in modulating cellular functions in neutrophils are
still poorly deﬁned.
We investigated the role of calcium in the potentiating
effectofnucleotides.Inneutrophilsmaintainedfor30minin
calcium-free medium in order to deplete the intracellular
stores, fMLP-triggered ROS production was inhibited and
the UTP-induced potentiation was greatly inhibited. How-
ever, under such experimental conditions it is difﬁcult to
assessthe degree ofcalciumdepletion ofintracellular stores.
Thapsigargin is the most widely used inhibitor of the
ubiquitous sarco-endoplasmic reticulum Ca
2+-ATPases in
mammalian cells [43]. Its high potency and selectivity have
been highly valuable in understanding the function of
intracellular calcium stores in different processes. Follow-
ing treatment with thapsigargin, neutrophils maintained in
calcium-free medium failed to produce ROS upon stimu-
lation with fMLP in the absence or presence of UTP.
However, when physiological concentrations of calcium
were present in the extracellular medium the fMLP-
mediated effect was restored, while no potentiating effect
of UTP was detected. The fact that thapsigargin can block
ROS production when neutrophils are placed in a calcium-
free medium but not in the presence of extracellular
calcium can be explained by the fact that NADPH oxidase
activity in neutrophils require the presence of calcium.
When extracellular calcium is present, thapsigargin triggers
store operated calcium entry that supplies the necessary
intracellular calcium. However, the potentiating effect of
UTP is blocked in the presence of thapsigargin that causes
depletion of calcium from endoplasmic reticulum. Our data
strongly suggest that the mobilization of calcium from
thapsigargin-sensitive stores is essential for the potentiat-
ing effect of UTP but it is not necessary for the fMLP-
induced ROS production. It is well known that IP3 is able
to release calcium from thapsigargin-sensitive calcium
stores, related to the endoplasmic reticulum, as well as
from thapsigargin-insensitive stores, such as Golgi calcium
pool [44]. Since fMLP and UTP induce IP3 formation in
human neutrophils [34], we next explored if disruption of
Golgi calcium pool by brefeldin A [45] can alter the
potentiating effect of UTP in a similar manner as
thapsigargin. Alteration of Golgi calcium stores had no
effect on UTP-induced potentiation of fMLP effect on
ROS production, suggesting that IP3-sensitive Golgi calci-
um pool is not involved in this process.
We conclude that calcium release from thapsigargin-
sensitive but not from Golgi intracellular stores is essential
for the priming effect of nucleotides. This mechanism of
controlling ROS production in neutrophils can be viewed
as a potential target for drugs that may be useful to treat
pathological conditions associated with excessive neutro-
phil activation [46], such as ischemiaYreperfusion and burn
injuries, arthritis and allergic reactions.
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